1. Home
  2. ANVS vs FTHM Comparison

ANVS vs FTHM Comparison

Compare ANVS & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • FTHM
  • Stock Information
  • Founded
  • ANVS 2008
  • FTHM 2010
  • Country
  • ANVS United States
  • FTHM United States
  • Employees
  • ANVS N/A
  • FTHM N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • FTHM Real Estate
  • Sector
  • ANVS Health Care
  • FTHM Finance
  • Exchange
  • ANVS Nasdaq
  • FTHM Nasdaq
  • Market Cap
  • ANVS 46.1M
  • FTHM 38.3M
  • IPO Year
  • ANVS 2020
  • FTHM 2020
  • Fundamental
  • Price
  • ANVS $2.05
  • FTHM $1.74
  • Analyst Decision
  • ANVS Strong Buy
  • FTHM Strong Buy
  • Analyst Count
  • ANVS 4
  • FTHM 1
  • Target Price
  • ANVS $17.33
  • FTHM $2.50
  • AVG Volume (30 Days)
  • ANVS 1.3M
  • FTHM 272.9K
  • Earning Date
  • ANVS 11-12-2025
  • FTHM 11-11-2025
  • Dividend Yield
  • ANVS N/A
  • FTHM N/A
  • EPS Growth
  • ANVS N/A
  • FTHM N/A
  • EPS
  • ANVS N/A
  • FTHM N/A
  • Revenue
  • ANVS N/A
  • FTHM $390,032,000.00
  • Revenue This Year
  • ANVS N/A
  • FTHM $25.22
  • Revenue Next Year
  • ANVS N/A
  • FTHM $16.19
  • P/E Ratio
  • ANVS N/A
  • FTHM N/A
  • Revenue Growth
  • ANVS N/A
  • FTHM 19.16
  • 52 Week Low
  • ANVS $1.11
  • FTHM $0.65
  • 52 Week High
  • ANVS $10.54
  • FTHM $3.37
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 47.27
  • FTHM 48.20
  • Support Level
  • ANVS $1.97
  • FTHM $1.54
  • Resistance Level
  • ANVS $2.23
  • FTHM $1.92
  • Average True Range (ATR)
  • ANVS 0.18
  • FTHM 0.15
  • MACD
  • ANVS 0.02
  • FTHM -0.00
  • Stochastic Oscillator
  • ANVS 45.15
  • FTHM 50.00

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

Share on Social Networks: